Loading...
XNYSHIMS
Market cap5.41bUSD
Jan 08, Last price  
25.73USD
1D
-7.01%
1Q
44.15%
IPO
158.59%
Name

Hims & Hers Health Inc

Chart & Performance

D1W1MN
XNYS:HIMS chart
P/E
P/S
6.20
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
25.48%
Rev. gr., 5y
100.85%
Revenues
872m
+65.49%
26,679,00082,558,000148,757,000271,878,000526,916,000872,000,000
Net income
-24m
L-64.15%
-75,243,000-72,064,000-18,114,000-107,659,000-65,678,000-23,546,000
CFO
73m
P
-57,322,000-74,867,000-2,479,000-34,412,000-26,531,00073,483,000
Earnings
Feb 24, 2025

Profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
IPO date
Sep 09, 2019
Employees
651
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
872,000
65.49%
526,916
93.81%
Cost of revenue
781,596
518,210
Unusual Expense (Income)
NOPBT
90,404
8,706
NOPBT Margin
10.37%
1.65%
Operating Taxes
1,975
(31)
Tax Rate
2.18%
NOPAT
88,429
8,737
Net income
(23,546)
-64.15%
(65,678)
-38.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,999)
(1,655)
BB yield
0.11%
0.13%
Debt
Debt current
2,562
1,658
Long-term debt
18,615
8,956
Deferred revenue
Other long-term liabilities
22
3,010
Net debt
(199,804)
(169,867)
Cash flow
Cash from operating activities
73,483
(26,531)
CAPEX
(17,220)
(7,247)
Cash from investing activities
(12,106)
34,699
Cash from financing activities
(11,475)
(33,127)
FCF
47,634
8,912
Balance
Cash
220,981
179,625
Long term investments
856
Excess cash
177,381
154,135
Stockholders' equity
(368,278)
(344,885)
Invested Capital
723,558
663,980
ROIC
12.75%
1.36%
ROCE
25.45%
2.73%
EV
Common stock shares outstanding
209,345
204,516
Price
8.90
38.85%
6.41
-2.14%
Market cap
1,863,168
42.12%
1,310,948
7.15%
EV
1,663,364
1,141,081
EBITDA
99,919
16,180
EV/EBITDA
16.65
70.52
Interest
2,988
Interest/NOPBT
34.32%